Differentiating Combined Hepatocellular and Cholangioc cinoma from Mass-Forming Intrahepatic Chol gioc cinoma Using Gadoxetic Acid-Enh ced MRI

被引:71
作者
Hwang, Jiyoung
Kim, Young Kon [1 ,2 ]
Park, Min Jung
Lee, Mi Hee
Kim, Seong Hyun
Lee, Won Jae
Rhim, Hyun Chul
机构
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Radiol, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Ctr Imaging Sci, Seoul, South Korea
关键词
CLINICAL-FEATURES; CARCINOMA; LIVER; EFFICACY; CT;
D O I
10.1002/jmri.23728
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To examine the differential features of combined hepatocellular and cholangiocarcinoma (HCC-CC) from mass-forming intrahepatic cholangiocarcinoma (ICC) on gadoxetic acid-enhanced MRI. Materials and Methods: Forty patients with pathologically proven combined HCC-CC (n = 20) and ICCs (n = 20) who had undergone gadoxetic acid-enhanced MRI were enrolled in this study. MR images were analyzed for the shape of lesions, hypo- or hyperintense areas on the T2-weighted image (T2WI), rim enhancement during early dynamic phases, and central enhancement with hypointense rim (target appearance) on the 10-min and 20-min hepatobiliary phase (HBP). The significance of these findings was determined by the χ2 test. Results: Irregular shape and strong rim enhancement during early dynamic phases, and absence of target appearance on HBP favored combined HCC-CCs (P < 0.05). Lobulated shape, weak peripheral rim enhancement, and the presence of complete target appearance on the 10-min and 20-min HBP favored ICCs (P < 0.05). However, 10 CC-predominant type of combined HCC-CC showed complete or partial target appearance on 10-min HBP. Conclusion: The shape of tumors, degree of rim enhancement during early dynamic phases, and target appearance on HBP were valuable for differentiating between combined HCC-CC and mass-forming ICC on gadoxetic acid-enhanced MRI. © 2012 Wiley Periodicals, Inc.
引用
收藏
页码:881 / 889
页数:9
相关论文
共 29 条
[1]  
ALLEN RA, 1949, AM J PATHOL, V25, P647
[2]  
[Anonymous], 1990, ANN SURG, V211, P277
[3]  
AOKI K, 1993, HEPATOLOGY, V18, P1090
[4]   Biliary and reticuloendothelial impairment in hepatocarcinogenesis: the diagnostic role of tissue-specific MR contrast media [J].
Bartolozzi, Carlo ;
Crocetti, Laura ;
Lencioni, Riccardo ;
Cioni, Dania ;
Della Pina, Clotilde ;
Campani, Daniela .
EUROPEAN RADIOLOGY, 2007, 17 (10) :2519-2530
[5]   Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai population [J].
Chantajitr, Songyos ;
Wilasrusmee, Chumpon ;
Lertsitichai, Phanuwat ;
Phromsopha, Ninatthanan .
JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY, 2006, 13 (06) :537-542
[6]   PERIPHERAL CHOLANGIOCARCINOMA - COMPARISON OF MRI WITH CT [J].
CHOI, BI ;
HAN, JK ;
SHIN, YM ;
BAEK, SY ;
HAN, MC .
ABDOMINAL IMAGING, 1995, 20 (04) :357-360
[7]   Characterization of Cirrhotic Nodules With Gadoxetic Acid-Enhanced Magnetic Resonance Imaging: The Efficacy of Hepatocyte-Phase Imaging [J].
Chou, Chen-Te ;
Chen, Yao-Li ;
Su, Wei-Wen ;
Wu, Hwa-Koon ;
Chen, Ran-Chou .
JOURNAL OF MAGNETIC RESONANCE IMAGING, 2010, 32 (04) :895-902
[8]   INTRAHEPATIC CHOLANGIOCARCINOMA - SPIN-ECHO AND CONTRAST-ENHANCED DYNAMIC MR-IMAGING [J].
FAN, ZM ;
YAMASHITA, Y ;
HARADA, M ;
BABA, Y ;
YAMAMOTO, H ;
MATSUKAWA, T ;
ARAKAWA, A ;
MIYAZAKI, T ;
TAKAHASHI, M .
AMERICAN JOURNAL OF ROENTGENOLOGY, 1993, 161 (02) :313-317
[9]   Delayed MR imaging of the liver: correlation of delayed enhancement of hepatic tumors and pathologic appearance [J].
Gabata, T ;
Matsui, O ;
Kadoya, M ;
Yoshikawa, J ;
Ueda, K ;
Kawamori, Y ;
Takashima, T ;
Nonomura, A .
ABDOMINAL IMAGING, 1998, 23 (03) :309-313
[10]  
GOODMAN ZD, 1985, CANCER-AM CANCER SOC, V55, P124, DOI 10.1002/1097-0142(19850101)55:1<124::AID-CNCR2820550120>3.0.CO